Purchases and Sales Made in Q4 2023 in Pharma Cyte Biotech, Inc. (PMCB)
This table provides information about the institutional ownership of Pharma Cyte Biotech, Inc. (PMCB) during Q4 2023. The information is specifically focused on institutions that hold shares of PharmaCyte Biotech, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 14, 2024
Q4 2023
|
K2 Principal Fund, L.P.
Toronto, A6 |
BUY
|
- |
46.1K+ 17.85% |
$92.7K - $108K
|
305K
$478K
|
|
|
Feb 14, 2024
Q4 2023
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
BUY
|
- |
22KNew |
$44.3K - $51.5K
|
22K
$34.6K
|
|
|
Feb 14, 2024
Q4 2023
|
Squarepoint Ops LLC
New York, NY |
BUY
|
- |
14.8KNew |
$29.8K - $34.7K
|
14.8K
$23.3K
|
|
|
Feb 13, 2024
Q4 2023
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
BUY
|
- |
5.2K+ 15.81% |
$10.5K - $12.2K
|
38.1K
$59.8K
|
|
|
Feb 14, 2024
Q4 2023
|
Vanguard Group Inc
Valley Forge, PA |
BUY
|
- |
2.41K+ 1.43% |
$4.85K - $5.65K
|
171K
$269K
|
|
|
Feb 13, 2024
Q4 2023
|
Tower Research Capital LLC (Trc)
New York, NY |
BUY
|
- |
657+ 53.94% |
$1.32K - $1.54K
|
1.88K
$2.94K
|
|
|
Feb 14, 2024
Q4 2023
|
Royal Bank Of Canada
Toronto, A6 |
BUY
|
- |
167+ 170.41% |
$336 - $391
|
265
$416
|
|
|
Feb 08, 2024
Q4 2023
|
Private Wealth Management Group, LLC
Princeton, NJ |
BUY
|
- |
42New |
$84.4 - $98.3
|
42
$65.9
|
|
|
Feb 09, 2024
Q4 2023
|
Covestor LTD
Boston, MA |
BUY
|
- |
37+ 19.58% |
$74.4 - $86.6
|
226
$355
|
|
|
Feb 09, 2024
Q4 2023
|
Sachetta, LLC
Lynnfield, MA |
BUY
|
- |
14New |
$28.1 - $32.8
|
14
$22
|
|
|
Feb 13, 2024
Q4 2023
|
Northwestern Mutual Wealth Management CO
|
BUY
|
- |
14New |
$28.1 - $32.8
|
14
$22
|
|
|
Feb 14, 2024
Q4 2023
|
Bank Of America Corp
Charlotte, NC |
BUY
|
- |
8+ 14.81% |
$16.1 - $18.7
|
62
$97.3
|
|
|
Feb 09, 2024
Q4 2023
|
Ubs Group Ag
|
BUY
|
- |
4+ 44.44% |
$8.04 - $9.36
|
13
$20.4
|
|
|
Feb 09, 2024
Q4 2023
|
Wells Fargo & Company
San Francisco, CA |
BUY
|
- |
2+ 3.77% |
$4.02 - $4.68
|
55
$86.4
|
|
|
Feb 13, 2024
Q4 2023
|
Morgan Stanley
New York, NY |
BUY
|
- |
1+ 33.33% |
$2.01 - $2.34
|
4
$6.28
|
|
|
Aug 16, 2024
Q4 2023
|
Morgan Stanley
New York, NY |
BUY
|
- |
1+ 33.33% |
$2.01 - $2.34
|
4
$6.28
|
|
|
Feb 07, 2024
Q4 2023
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
Feb 12, 2024
Q4 2023
|
Jpmorgan Chase & CO
New York, NY |
SELL
|
- |
-5- 29.41% |
$10 - $11.7
|
12
$18.8
|
|
|
Dec 26, 2024
Q4 2023
|
Jpmorgan Chase & CO
New York, NY |
SELL
|
- |
-6- 33.33% |
$12.1 - $14
|
12
$18.8
|
|
|
Feb 14, 2024
Q4 2023
|
Schonfeld Strategic Advisors LLC
New York, NY |
SELL
|
- |
-100- 0.43% |
$201 - $234
|
23.2K
$36.4K
|
|
|
Feb 12, 2024
Q4 2023
|
Advisor Group Holdings, Inc.
Phoenix, AZ |
SELL
|
- |
-213- 10.81% |
$428 - $498
|
1.76K
$2.76K
|
|
|
Feb 13, 2024
Q4 2023
|
Acadian Asset Management LLC
Boston, MA |
SELL
|
- |
-2.34K- 32.8% |
$4.7K - $5.47K
|
4.79K
$7.52K
|
|
|
Feb 13, 2024
Q4 2023
|
Geode Capital Management, LLC
Boston, MA |
SELL
|
- |
-3.47K- 1.59% |
$6.98K - $8.13K
|
216K
$339K
|
|
|
Feb 14, 2024
Q4 2023
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
- |
-6.77K- 19.12% |
$13.6K - $15.8K
|
28.6K
$44.9K
|
|
|
Feb 13, 2024
Q4 2023
|
Black Rock Inc.
New York, NY |
SELL
|
- |
-12.9K- 31.03% |
$26K - $30.3K
|
28.8K
$45.2K
|
|
|
Feb 14, 2024
Q4 2023
|
Sabby Management, LLC
Upper Saddle River, NJ |
SELL
|
- |
-14.8K- 15.19% |
$29.6K - $34.5K
|
82.4K
$129K
|